These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 19913840)
1. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. Onat A; Hergenç G; Can G; Kaya Z; Yüksel H Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840 [TBL] [Abstract][Full Text] [Related]
2. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402 [TBL] [Abstract][Full Text] [Related]
3. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975 [TBL] [Abstract][Full Text] [Related]
4. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Onat A; Can G; Hergenç G Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050 [TBL] [Abstract][Full Text] [Related]
5. Complement C3 and cleavage products in cardiometabolic risk. Onat A; Can G; Rezvani R; Cianflone K Clin Chim Acta; 2011 Jun; 412(13-14):1171-9. PubMed ID: 21419112 [TBL] [Abstract][Full Text] [Related]
6. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men. Onat A; Hergenç G; Can G; Küçükdurmaz Z Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men. Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks. Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102 [TBL] [Abstract][Full Text] [Related]
9. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827 [TBL] [Abstract][Full Text] [Related]
10. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Zabetian A; Hadaegh F; Azizi F Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915 [TBL] [Abstract][Full Text] [Related]
11. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Onat A; Can G; Ayhan E; Kaya Z; Hergenç G Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555 [TBL] [Abstract][Full Text] [Related]
12. Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Nakamura H; Ito H; Egami Y; Kaji Y; Maruyama T; Koike G; Jingu S; Harada M Diabetes Res Clin Pract; 2008 Feb; 79(2):330-6. PubMed ID: 17964679 [TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study. Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819 [TBL] [Abstract][Full Text] [Related]
14. Moderate and heavy alcohol consumption among Turks: long-term impact on mortality and cardiometabolic risk. Onat A; Hergenç G; Küçükdurmaz Z; Uğur M; Kaya Z; Can G; Yüksel H Turk Kardiyol Dern Ars; 2009 Mar; 37(2):83-90. PubMed ID: 19404028 [TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539 [TBL] [Abstract][Full Text] [Related]
16. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445 [TBL] [Abstract][Full Text] [Related]
17. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. Lim HS; Lip GY; Beevers DG; Blann AD Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044 [TBL] [Abstract][Full Text] [Related]
18. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067 [TBL] [Abstract][Full Text] [Related]
19. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834 [TBL] [Abstract][Full Text] [Related]
20. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study. Onat A; Sari I; Hergenç G; Yazici M; Uyarel H; Can G; Sansoy V Metabolism; 2007 Mar; 56(3):348-56. PubMed ID: 17292723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]